Peer-reviewedCC BYEuropace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology1 Oct 2026

The weight of evidence: does obesity really not matter for atrial fibrillation ablation? Lessons from CABANA.

Pascal Defaye¹
Moussa Mansour²
Luigi Di Biase³

¹Department of Cardiology, University Hospital Grenoble Alpes and Grenoble Alpes University, CHU Grenoble Alpes, CS 10217, Grenoble Cedex 9, Grenoble 38043, France.
²Cardiac Arrhythmia Service, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
³Department of Cardiac Electrophysiology, Albert Einstein College of Medicine at Montefiore Health System, Bronx, NY, USA.

Read full text PDF DOI Cite

Cardiometabolic Substrate Modification in Atrial Fibrillation: Obesity and Epicardial Adipose Tissue in the Era of Incretin-Based Therapies and Catheter Ablation
Andrea Matteucci, Michela Bonanni, Luca Sgarra +7
Journal of cardiovascular development and disease1 Oct 2026Peer-reviewedCC BYFull textCardiovascular medicineEurope PMC
Impact of obesity on clinical outcomes and the treatment effect of catheter ablation in atrial fibrillation: insights from CABANA
Jonas Erzeel, Sebastiaan Dhont, Marnicq van Es +9
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology1 Oct 2026Peer-reviewedCC BYFull text1 citedCardiovascular medicineEurope PMCEurope PMCPMC
Impact of obesity on procedural safety and 1-year outcomes after pulsed-field ablation for atrial fibrillation
Grégoire Massoullié, Corentin Chaumont, Mikael Laredo +45
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology1 Oct 2026Peer-reviewedCC BYFull textCardiovascular medicineEurope PMCEurope PMCPMC
Continuous glucose monitoring after discontinuation of incretin-based obesity pharmacotherapy: indirect evidence and a research framework for metabolic stability and weight maintenance
Andrijana Koceva, Andrej Janez, Mojca Jensterle
Frontiers in endocrinology16 Oct 2026Peer-reviewedCC BYFull textEndocrinology & metabolismEurope PMC
Obesity and Atrial Fibrillation: Weighing the Evidence
Francis J. Ha, Jit Yoei Tang, Shaun Khanna +3
Journal of Clinical Medicine19 Oct 2026Peer-reviewedCC BY 4.0Cardiovascular medicineCrossref

Cite

BibTeX RIS

BibTeX

@article{defaye2026weight,
  title = {{The weight of evidence: does obesity really not matter for atrial fibrillation ablation? Lessons from CABANA.}},
  author = {Pascal Defaye and Moussa Mansour and Luigi Di Biase},
  journal = {Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology},
  year = {2026},
  month = oct,
  doi = {10.1093/europace/euag290},
  url = {https://europepmc.org/article/MED/42954926},
  note = {CC BY},
}

RIS

TY  - JOUR
TI  - The weight of evidence: does obesity really not matter for atrial fibrillation ablation? Lessons from CABANA.
AU  - Pascal Defaye
AU  - Moussa Mansour
AU  - Luigi Di Biase
PY  - 2026
DA  - 2026/10/01
JO  - Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
DO  - 10.1093/europace/euag290
UR  - https://europepmc.org/article/MED/42954926
SN  - 1099-5129
SN  - 1532-2092
ER  -

Related

Cite